Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CYP26C1 contributors: shn - updated : 03-06-2012
HGNC name cytochrome P450, family 26, subfamily C, polypeptide 1
HGNC id 20577
Corresponding disease
FFDD4 focal facial dermal dysplasia 4
Location 10q23.33      Physical location : 94.821.020 - 94.828.453
Synonym name cytochrome p450 26C1
Synonym symbol(s) FLJ45301
EC.number 1.14.-.-
DNA
TYPE functioning gene
STRUCTURE 7.43 kb     6 Exon(s)
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked N status confirmed
Map cen - D10S583 - D10S1755 - CYP26C1 - D10S185 - D10S200 - qter
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
6 - 1569 - 522 - -
EXPRESSION
Type restricted
constitutive of
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Nervousbrain    
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
interspecies ortholog to Cyp26c1, Mus musculus
ortholog to Cyp26c1, Rattus norvegicus
ortholog to cyp26c1, Danio rerio
intraspecies homolog to CYP26B1
Homologene
FAMILY cytochrome P450 family
CATEGORY enzyme , transport
SUBCELLULAR LOCALIZATION     plasma membrane
basic FUNCTION
  • may play a specific role in catabolizing both all-trans and 9-cis isomers of retinoic acid (
  • required for correct A-P patterning and production of migratory cranial neural crest cells in the developing brain
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    text Metabolism of 9-cis and All-trans Isomers of Retinoic Acid (
    PATHWAY
    metabolism energetic , lipid/lipoprotein
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) FFDD4
    Susceptibility
    Variant & Polymorphism
    Candidate gene
  • nonsyndromic optic nerve aplasia (
  • Marker
    Therapy target
    ANIMAL & CELL MODELS